Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has failed to impress investors.
Oath Surgical, a new startup out of Portland, Ore., revealed more details about its outpatient surgical care business, touting the service as lower cost and higher quality compared to traditional hospital-based procedures.
Capitol Riot - capitol-riot.com
